Tivoxavir marboxil clinical trials
Also written TRX-100.
How each study uses tivoxavir marboxil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the tivoxavir marboxil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- TRX-100
- 4
Studies by the year they started
4 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test tivoxavir marboxil.
- Nov 2026Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelPhase 2 · Traws Pharma, Inc.
- Dec 2026This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaPhase 2 · Traws Pharma, Inc.
Studies
Open first, then newest update. How each study uses tivoxavir marboxil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy VolunteersRecruitingPhase 1Traws Pharma, Inc.NCT07526506Written as TRX-100
- Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelNot yet recruitingPhase 2Traws Pharma, Inc.NCT07503405Written as TRX-100
- This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaActive, not recruitingPhase 2Traws Pharma, Inc.NCT07371650Written as TRX-100
- A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy VolunteersCompletedPhase 1Traws Pharma, Inc.NCT06757738Written as TRX-100
Codes
What other systems call tivoxavir marboxil · ClinicalTrials.gg INT015695
- UNII (FDA) 8P73TA5CLCTIVOXAVIR MARBOXILConfirmed FDA, Wikidata
- Wikidata Q140529349tivoxavir marboxilConfirmed FDA, Wikidata
- NCI Thesaurus C215777Tivoxavir MarboxilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8P73TA5CLC | TIVOXAVIR MARBOXIL | Confirmed FDA, Wikidata |
| Wikidata | Q140529349 | tivoxavir marboxil | Confirmed FDA, Wikidata |
| NCI Thesaurus | C215777 | Tivoxavir Marboxil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.